ArticleThe Lancet. Infectious diseases2015
Towards real-time monitoring of artemisinin resistance.
Article in The Lancet. Infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mapping genetic markers of artemisinin resistance inThe Lancet. Microbe · 2022Pooled it
- A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine.Malaria journal · 2018Trial
- A LAMP-SNP Assay Detecting C580Y Mutation in Pfkelch13 Gene from Clinically Dried Blood Spot Samples.The Korean journal of parasitology · 2021Article
- Molecular docking analysis of Plasmodium falciparum dihydroorotate dehydrogenase towards the design of effective inhibitors.Bioinformation · 2020Article
- Ex vivo efficacy of selective chalcone derivatives on reference strains and field isolates ofPathogens and global health · 2019Article
- The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background.Nature communications · 2018Article
- Synthesis, Design, and Structure⁻Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors ofMolecules (Basel, Switzerland) · 2018Article
- A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants.Malaria journal · 2018Article
- Antimalarial Drug Resistance: A Threat to Malaria Elimination.Cold Spring Harbor perspectives in medicine · 2017Review
- A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria.ACS infectious diseases · 2016Article
- Malaria control along China-Myanmar Border during 2007-2013: an integrated impact evaluation.Infectious diseases of poverty · 2016Article
- A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.The New England journal of medicine · 2016Article
- Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production.Frontiers in plant science · 2016Review
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria.Science translational medicine · 2015Article
- Observing in real time the evolution of artemisinin resistance in Plasmodium falciparum.BMC medicine · 2015Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25704895What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.